Causality Assessment for Suspected Drug-Induced Liver Injury in Patients With Underlying Chronic Liver Disease
dc.contributor.author | Dakhoul, Lara | |
dc.contributor.author | Chalasani, Naga | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2019-08-01T17:11:19Z | |
dc.date.available | 2019-08-01T17:11:19Z | |
dc.date.issued | 2017-03-30 | |
dc.identifier.citation | Dakhoul, L., & Chalasani, N. (2017). Causality Assessment for Suspected Drug-Induced Liver Injury in Patients With Underlying Chronic Liver Disease. Clinical liver disease, 9(3), 63–65. doi:10.1002/cld.619 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/20097 | |
dc.language.iso | en_US | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | 10.1002/cld.619 | en_US |
dc.relation.journal | Clinical Liver Disease | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Drug‐induced liver injury (DILI) | en_US |
dc.subject | Liver disease | en_US |
dc.subject | Chronic liver disease | en_US |
dc.subject | Nonalcoholic fatty liver disease (NAFLD) | en_US |
dc.title | Causality Assessment for Suspected Drug-Induced Liver Injury in Patients With Underlying Chronic Liver Disease | en_US |
dc.type | Article | en_US |
ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467144/ | en_US |